[go: up one dir, main page]

CA2182004A1 - Comprimes enrobes de paracetamol et de domperidone - Google Patents

Comprimes enrobes de paracetamol et de domperidone

Info

Publication number
CA2182004A1
CA2182004A1 CA2182004A CA2182004A CA2182004A1 CA 2182004 A1 CA2182004 A1 CA 2182004A1 CA 2182004 A CA2182004 A CA 2182004A CA 2182004 A CA2182004 A CA 2182004A CA 2182004 A1 CA2182004 A1 CA 2182004A1
Authority
CA
Canada
Prior art keywords
domperidone
paracetamol
film coated
coated tablet
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2182004A
Other languages
English (en)
Other versions
CA2182004C (fr
Inventor
Gordon Prudhoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8216670&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2182004(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2182004A1 publication Critical patent/CA2182004A1/fr
Application granted granted Critical
Publication of CA2182004C publication Critical patent/CA2182004C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
CA002182004A 1994-02-28 1995-02-27 Comprimes enrobes de paracetamol et de domperidone Expired - Lifetime CA2182004C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94200498.7 1994-02-28
EP94200498 1994-02-28
PCT/EP1995/000719 WO1995022974A2 (fr) 1994-02-28 1995-02-27 Comprimes enrobes de paracetamol et de domperidone

Publications (2)

Publication Number Publication Date
CA2182004A1 true CA2182004A1 (fr) 1995-08-31
CA2182004C CA2182004C (fr) 2000-10-31

Family

ID=8216670

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002182004A Expired - Lifetime CA2182004C (fr) 1994-02-28 1995-02-27 Comprimes enrobes de paracetamol et de domperidone

Country Status (29)

Country Link
US (1) US5814339A (fr)
EP (1) EP0749308B1 (fr)
JP (1) JP2931409B2 (fr)
KR (1) KR100202154B1 (fr)
CN (1) CN1084616C (fr)
AT (1) ATE240102T1 (fr)
AU (1) AU703242B2 (fr)
BR (1) BR9506903A (fr)
CA (1) CA2182004C (fr)
CY (1) CY2383B1 (fr)
CZ (1) CZ291999B6 (fr)
DE (1) DE69530759T2 (fr)
DK (1) DK0749308T3 (fr)
ES (1) ES2199982T3 (fr)
FI (1) FI117373B (fr)
HU (1) HU228149B1 (fr)
IL (1) IL112802A (fr)
MX (1) MX9603690A (fr)
MY (1) MY115433A (fr)
NO (1) NO309455B1 (fr)
NZ (1) NZ281236A (fr)
PL (1) PL179080B1 (fr)
PT (1) PT749308E (fr)
RU (1) RU2153337C2 (fr)
SI (1) SI0749308T1 (fr)
SK (1) SK282506B6 (fr)
TW (1) TW466119B (fr)
WO (1) WO1995022974A2 (fr)
ZA (1) ZA951616B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
GB9702392D0 (en) * 1997-02-06 1997-03-26 Boots Co Plc Therapeutic agents
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
RU2266744C2 (ru) * 2001-06-21 2005-12-27 Duchesnay Ink. Композиция быстрого начала действия
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
RU2192848C1 (ru) * 2001-10-30 2002-11-20 Закрытое акционерное общество "ВЕРОФАРМ" Противорвотное средство
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
RU2268047C2 (ru) * 2003-12-15 2006-01-20 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая противорвотным действием, и способ ее изготовления
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
EP2142176A1 (fr) * 2007-04-26 2010-01-13 Craig A. Aronchick Compositions et procédés de délivrance de dompéridone par voie transmuqueuse
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
CA2704209C (fr) 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Forme de dosage a desintegration orale
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
FR2992218B1 (fr) * 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
EP3091966B1 (fr) 2014-01-10 2019-07-31 Johnson & Johnson Consumer Inc. Procédé pour fabriquer un comprimé par radiofréquence et particules revêtues à perte
KR102851614B1 (ko) 2016-02-04 2025-08-29 신돔 파마, 인크. 장애 치료를 위한 중수소화된 돔페리돈 조성물 및 방법
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US12478612B2 (en) 2017-06-30 2025-11-25 Cindome Pharma, Inc. Deuterated domperidone compositions, methods, and preparation
KR20240125702A (ko) 2017-06-30 2024-08-19 신돔 파마, 인크. 중수소화 돔페리돈 조성물, 방법, 및 제조
CN110302169A (zh) * 2019-08-01 2019-10-08 张慧芬 一种滑膜衣片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528098B2 (en) * 1978-11-16 1983-04-14 Beecham Group Plc Analgesic tablet
CA2020018A1 (fr) * 1990-06-27 1991-12-28 Don L. Simmons Methode et compose pour le traitement du complexe migraineux
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
CA2139638A1 (fr) * 1992-07-07 1994-01-20 Nancy M. Gray Methodes d'utilisation de la (-) cisapride pour le traitement du reflux gastro-oesophagien et d'autres troubles
RU2068689C1 (ru) * 1992-09-24 1996-11-10 Товарищество с ограниченной ответственностью "Лекрон" Способ получения таблеток парацетамола
TW272942B (fr) * 1993-02-10 1996-03-21 Takeda Pharm Industry Co Ltd
RU2034533C1 (ru) * 1993-02-25 1995-05-10 Химико-фармацевтическое акционерное общество открытого типа "Октябрь" Анальгезирующее жаропонижающее лекарственное средство и способ его получения

Also Published As

Publication number Publication date
KR100202154B1 (ko) 1999-06-15
HK1010687A1 (en) 1999-06-25
EP0749308A1 (fr) 1996-12-27
WO1995022974A2 (fr) 1995-08-31
DE69530759T2 (de) 2004-03-18
PT749308E (pt) 2003-10-31
AU703242B2 (en) 1999-03-25
CZ291999B6 (cs) 2003-07-16
PL179080B1 (pl) 2000-07-31
ATE240102T1 (de) 2003-05-15
DK0749308T3 (da) 2003-09-01
NZ281236A (en) 2001-11-30
PL314850A1 (en) 1996-09-30
JP2931409B2 (ja) 1999-08-09
CZ225596A3 (en) 1996-11-13
ZA951616B (en) 1996-08-27
EP0749308B1 (fr) 2003-05-14
IL112802A0 (en) 1995-05-26
FI117373B (fi) 2006-09-29
NO309455B1 (no) 2001-02-05
FI962156L (fi) 1996-06-04
SI0749308T1 (en) 2003-10-31
DE69530759D1 (de) 2003-06-18
MX9603690A (es) 1997-06-28
MY115433A (en) 2003-06-30
HU9601384D0 (en) 1996-07-29
CY2383B1 (en) 2004-06-04
HU228149B1 (en) 2012-12-28
CN1141589A (zh) 1997-01-29
WO1995022974A3 (fr) 1995-09-21
HUT74477A (en) 1996-12-30
NO962153D0 (no) 1996-05-28
BR9506903A (pt) 1997-09-09
IL112802A (en) 1999-08-17
FI962156A0 (fi) 1996-05-22
NO962153L (no) 1996-08-26
SK282506B6 (sk) 2002-10-08
CN1084616C (zh) 2002-05-15
US5814339A (en) 1998-09-29
TW466119B (en) 2001-12-01
JPH09500910A (ja) 1997-01-28
AU1812395A (en) 1995-09-11
RU2153337C2 (ru) 2000-07-27
CA2182004C (fr) 2000-10-31
SK103296A3 (en) 1997-03-05
ES2199982T3 (es) 2004-03-01

Similar Documents

Publication Publication Date Title
CA2182004A1 (fr) Comprimes enrobes de paracetamol et de domperidone
CA2186039A1 (fr) Nouvelle forme galenique pharmaceutique orale
CA2154424A1 (fr) 1-phenyl-3-dimethylaminopropane possedant des proprietes pharmaceutiques
CA2170647A1 (fr) Forme posologique sous forme de comprime composite (i)
CA2180816A1 (fr) 6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
CA2166483A1 (fr) Nouvelle formulation pharmaceutique
ATE303140T1 (de) Tramadolhaltiges arzneimittel mit gesteuerter wirkstoffabgabe
EP1452172A3 (fr) Préparation pharmaceutique composite.
CA2066248A1 (fr) Esters d'acides thiophenecarboxyliques et d'aminoalcools; composes quaternaires obtenus par cette voie; production et utilisation de ces substances
CA2145513A1 (fr) Comprime pouvant liberer a differentes vitesses un ou plusieurs medicaments
CA2213996A1 (fr) Formes galeniques par voie orale comprenant un inhibiteur de la pompe a protons et un agent antiacide ou un alginate
HUT73768A (en) Extended release, film-coated tablet of astemizole and pseudoephedrine
HU0301171D0 (en) Antifungal active ingredients, pharmaceutical compositions containing the same and process for their preparation
CA2386690A1 (fr) Sels pharmaceutiques de tramadol
CA2199679A1 (fr) Composes de dimethyl-(3-aryl-but-3-enyl)-amine comme ingredients actifs dans des produits pharmaceutiques
CA2180810A1 (fr) Comprimes stabilises d'acide acetylsalicylique enrobes de gelatine
EP1167354A3 (fr) Huperzine A racémique
CZ10095A3 (en) Tablet with enhanced biological access of clodronic acid active component, packaging of such tablets and the use of the active component for the preparation of the tablets and process of producing such tablets
CA2220019A1 (fr) Composition pharmaceutique contenant de l'hydrochlorure de tiagabine et procede de preparation
JPS5759813A (en) Alpha-glucosidase inhibitor
CZ44395A3 (en) Hydroxylamines exhibiting hypoglycemic activity, process of their preparation, their use and pharmaceutical compositions containing thereof
CA2161683A1 (fr) Composition pour medecine veterinaire, renfermant un inhibiteur de la pompe a protons

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150227